Seikagaku Corporation (TYO:4548)
Japan flag Japan · Delayed Price · Currency is JPY
635.00
+10.00 (1.60%)
Jul 18, 2025, 1:42 PM JST

Seikagaku Company Description

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and HERNICORE for the treatment of lumbar disc herniation.

The company also offers bulk products comprising sodium hyaluronate and sodium chondroitin sulfate for use in pharmaceuticals and cosmetics.

In addition, it develops endotoxin-detecting reagents for use in quality control of injectable pharmaceuticals and medical devices manufacturing processes and water quality control of dialysate under the brands, such as Pyrochrome, ENDOSPECY, TOXICOLOR, etc. Additionally, its products under development include SI-6603 for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; SI-613 for knee osteoarthritis; SI-722 to treat interstitial cystitis and bladder pain syndrome; SI-613-ETP to treat enthesopathy; and SI-449, a cross-linked chondroitin sulfate adhesion barrier.

The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962.

Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

Seikagaku Corporation
CountryJapan
Founded1947
IndustryMedical Devices
SectorHealthcare
Employees1,075
CEOKenji Mizutani

Contact Details

Address:
Marunouchi Center Building
Tokyo, 100-0005
Japan
Phone81 3 5220 8950
Websiteseikagaku.co.jp

Stock Details

Ticker Symbol4548
ExchangeTokyo Stock Exchange
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3414000004
SIC Code2834

Key Executives

NamePosition
Kenji MizutaniChief Executive Officer
Kazushi TakedaChief Financial Officer